Liquidia Corporation (NASDAQ:LQDA) announced today that the U.S. Food and Drug Administration (FDA) has approved YUTREPIA ...

The FDA approved Yutrepia inhalation powder for the treatment of pulmonary arterial hypertension and pulmonary hypertension ...

Tianeptine, an opioid commonly referred to as "gas station heroin," is putting public health at risk, according to the FDA.

MORRISVILLE, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary ...

LTI-03 is formulated as a dry powder inhalation therapy that's designed to help ease fibrosis and symptoms of idiopathic ...

"Intentional misuse or inhalation of contents can lead to ... The U.S. Food and Drug Administration is warning that certain half-shell oysters that are frozen and raw harvested in South Korea ...